Understand the source comparison
Fat Loss Versus Lean Mass Loss
Any substantial, rapid weight loss — whether from dieting, surgery, or medication — includes some loss of lean body mass alongside fat. This is not unique to GLP-1 drugs, but the sheer magnitude of weight loss they produce makes the issue salient. In the SURMO
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Any substantial, rapid weight loss — whether from dieting, surgery, or medication — includes some loss of lean body mass alongside fat. This is not unique to GLP-1 drugs, but the sheer magnitude of weight loss they produce makes the issue salient. In the SURMOUNT-1 tirzepatide trial, participants lost proportionally far more fat than lean tissue, with a roughly three-fold greater reduction in fat mass than in lean mass.[9] Still, preserving muscle during treatment is a genuine concern, particularly for older adults in whom muscle loss can affect strength and function. The practical countermeasures are consistent across the literature: adequate protein intake and regular resistance exercise, which together shift the composition of weight loss toward fat and help maintain metabolically active muscle.